Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GB-0998 in Steroid-resistant Polymyositis and Dermatomyositis
jRCT2080220256Phase 3Completed
- Sponsor
- Japan Blood Products Organization
- Start
- Jun 2006
- Countries
- 1
01
Overview
Phase 3, randomised trial in polymyositis (PM) and dermatomyositis (DM) comparing GB-0998 with Placebo (2 arms). Primary endpoint: Manual muscle test score. Started Jun 2006; status: completed.
02
Drugs
polyvalent human immunoglobulin
03
Conditions
polymyositis (PM)dermatomyositis (DM)
Beyond the preview
Go deeper on jRCT2080220256.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220256.